Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supreme Court Suggests Setting Limits On Business Method Patents

This article was originally published in The Pink Sheet Daily

Executive Summary

In case that could have implications for patents on medical processes, justices question the Federal Circuit's application of the "machine-or-transformation" standard in Bilski v. Kappos.

You may also be interested in...



Patent Office Takes First Steps Toward Implementing Bilski Decision

While the Supreme Court's ruling in Bilski v. Kappos left several questions unanswered, the U.S. Patent and Trademark Office is prepared to implement the decision

Patent Office Takes First Steps Toward Implementing Bilski Decision

While the Supreme Court's ruling in Bilski v. Kappos left several questions unanswered, the U.S. Patent and Trademark Office is prepared to implement the decision

PTO Creates Task Force To Respond To Upcoming Bilski Decision

PTO wants government to back Myriad in its appeal of gene patent ruling, agency's Arti Rai says at BIO IP conference. PTO seeks to reduce patent pendency through patent reform and a fast-track review option.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS068847

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel